We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BINI
4101
DELISTED
Bollinger Innovations
BINI
0
LUXE
4102
LuxExperience B.V.
LUXE
$1.05B
$12K ﹤0.01%
1,668
+1,604
+2,506% +$14.6K
NC icon
4103
NACCO Industries
NC
$322M
$12K ﹤0.01%
332
+36
+12% +$1.35K
NEAR icon
4104
iShares Short Maturity Bond ETF
NEAR
$4.88B
$12K ﹤0.01%
+235
New +$11.6K
NEPH icon
4105
Nephros
NEPH
$50.3M
$12K ﹤0.01%
11,410
-1,712
-13% -$1.97K
NL icon
4106
NLI Holdings
NL
$315M
$12K ﹤0.01%
1,988
+725
+57% +$5.03K
NTGR icon
4107
NETGEAR
NTGR
$656M
$12K ﹤0.01%
669
-7,479
-92% -$140K
OLP
4108
One Liberty Properties
OLP
$529M
$12K ﹤0.01%
505
-543
-52% -$12.5K
OPBK icon
4109
OP Bancorp
OPBK
$233M
$12K ﹤0.01%
1,359
+381
+39% +$4.11K
OPOF
4110
DELISTED
Old Point Financial
OPOF
$12K ﹤0.01%
509
+449
+748% +$11.2K
PACK icon
4111
Ranpak Holdings
PACK
$478M
$12K ﹤0.01%
2,292
+1,625
+244% +$10.3K
PHAT icon
4112
Phathom Pharmaceuticals
PHAT
$775M
$12K ﹤0.01%
1,705
+1,219
+251% +$10.7K
PIII icon
4113
P3 Health Partners
PIII
$35.6M
$12K ﹤0.01%
223
+136
+156% +$8.17K
PNNT
4114
Pennant Park Investment Corp
PNNT
$243M
$12K ﹤0.01%
2,339
+1,073
+85% +$6.08K
QUAL icon
4115
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$12K ﹤0.01%
100
+63
+170% +$7.56K
REFI
4116
Chicago Atlantic Real Estate Finance
REFI
$260M
$12K ﹤0.01%
880
-1,307
-60% -$19.1K
RLYB icon
4117
Rallybio
RLYB
$90.2M
$12K ﹤0.01%
257
+124
+93% +$6.41K
SEER icon
4118
Seer Inc
SEER
$115M
$12K ﹤0.01%
3,065
-17,354
-85% -$79.8K
SIEB icon
4119
Siebert Financial
SIEB
$78.9M
$12K ﹤0.01%
6,702
+2,439
+57% +$4.21K
SILO icon
4120
Silo Pharma
SILO
$4.01M
$12K ﹤0.01%
366
+288
+369% +$10.5K
SLS icon
4121
SELLAS Life Sciences
SLS
$2.58B
$12K ﹤0.01%
8,576
+7,370
+611% +$18.2K
SSBK
4122
DELISTED
Southern States Bancshares
SSBK
$12K ﹤0.01%
528
-33
-6% -$904
SSKN
4123
DELISTED
Strata Skin Sciences
SSKN
$12K ﹤0.01%
1,115
-80
-7% -$804
SYPR icon
4124
Sypris Solutions
SYPR
$47.4M
$12K ﹤0.01%
5,884
+1,230
+26% +$2.44K
TBI
4125
Trueblue
TBI
$311M
$12K ﹤0.01%
648
+206
+47% +$3.85K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.